These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20718987)

  • 1. RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.
    Arora S; Gonzales IM; Hagelstrom RT; Beaudry C; Choudhary A; Sima C; Tibes R; Mousses S; Azorsa DO
    Mol Cancer; 2010 Aug; 9():218. PubMed ID: 20718987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated chemical biology approach identifies specific vulnerability of Ewing's sarcoma to combined inhibition of Aurora kinases A and B.
    Winter GE; Rix U; Lissat A; Stukalov A; Müllner MK; Bennett KL; Colinge J; Nijman SM; Kubicek S; Kovar H; Kontny U; Superti-Furga G
    Mol Cancer Ther; 2011 Oct; 10(10):1846-56. PubMed ID: 21768330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
    Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
    J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
    Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
    BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIPE1 inhibits the growth of Ewing's sarcoma cells by suppressing Wnt/β-catenin signaling.
    Wang Z; Sun L; Liu S; Jiang H
    Clin Transl Oncol; 2023 May; 25(5):1332-1339. PubMed ID: 36495466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.
    Guan H; Zhou Z; Gallick GE; Jia SF; Morales J; Sood AK; Corey SJ; Kleinerman ES
    Mol Cancer Ther; 2008 Jul; 7(7):1807-16. PubMed ID: 18644993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
    Kinsey M; Smith R; Lessnick SL
    Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma.
    Greve B; Sheikh-Mounessi F; Kemper B; Ernst I; Götte M; Eich HT
    Strahlenther Onkol; 2012 Nov; 188(11):1038-47. PubMed ID: 23053158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.
    Merchant MS; Woo CW; Mackall CL; Thiele CJ
    J Natl Cancer Inst; 2002 Nov; 94(22):1673-9. PubMed ID: 12441322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
    Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
    Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma.
    Boro A; Prêtre K; Rechfeld F; Thalhammer V; Oesch S; Wachtel M; Schäfer BW; Niggli FK
    Int J Cancer; 2012 Nov; 131(9):2153-64. PubMed ID: 22323082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
    Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
    Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.
    Awad O; Yustein JT; Shah P; Gul N; Katuri V; O'Neill A; Kong Y; Brown ML; Toretsky JA; Loeb DM
    PLoS One; 2010 Nov; 5(11):e13943. PubMed ID: 21085683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
    Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
    J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic anticancer activity of combined ATR and ribonucleotide reductase inhibition in Ewing's sarcoma cells.
    Sturm MJ; Henao-Restrepo JA; Becker S; Proquitté H; Beck JF; Sonnemann J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8605-8617. PubMed ID: 37097390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.
    Ban J; Jug G; Mestdagh P; Schwentner R; Kauer M; Aryee DN; Schaefer KL; Nakatani F; Scotlandi K; Reiter M; Strunk D; Speleman F; Vandesompele J; Kovar H
    Oncogene; 2011 May; 30(18):2173-80. PubMed ID: 21217773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway.
    Krishnan K; Bruce B; Hewitt S; Thomas D; Khanna C; Helman LJ
    Clin Exp Metastasis; 2006; 23(3-4):227-36. PubMed ID: 17028919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].
    Delaplace M; Mélard P; Perrinaud A; Goré C; Vergier B; Machet L
    Ann Dermatol Venereol; 2011 May; 138(5):395-8. PubMed ID: 21570564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.